Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Multi target Kinase Inhibition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108794474B reveals novel evodiamine derivatives targeting Top1/Top2/HDAC. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Novel quinoline kinase inhibitor synthesis offers high yield and purity for pharmaceutical intermediates, ensuring cost reduction and supply chain reliability.